Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Dementia Patients Are More Likely To End Up in Low-Quality Nursing Homes: StudyHigher quality nursing homes are able to provide better care for dementia patients, but researchers indicate they are less likely to admit these patients to their facilities. November 8, 2024 Michael Adams Add Your CommentsAlthough they need more specialized care and are unable to advocate for themselves, new research suggests that dementia patients are more likely to be admitted to lower quality long-term care facilities, where they may face an increased risk of injuries from nursing home neglect.Medical professionals often divide nursing homes into a two-tiered system, with those in the lower tier usually having more limited resources, and subsequently demonstrating lower quality measures and facing more nursing home negligence lawsuits.It has also been known for quite some time that nursing homes in the lower tier have more dementia patients than facilities that provide higher quality care. However, the reason for this disparity has not been well understood.In a new study published last week in Alzheimerโs & Dementia, the journal of the American Alzheimerโs Association, researchers indicate that dementia patients are less likely to be admitted to top tier facilities following a hospital stay, suggesting that this may be the result of higher costs associated with their care, which may negatively impact revenues for the facilities.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe research was led by Cyrus M. Kosar, of the Department of Health Services at Brown University in Providence, Rhode Island, looking at data for traditional Medicare beneficiaries who were discharged from hospitals to nursing homes between 2011 and 2017.Kosarโs team reviewed both hospital readmission and mortality data for the patients within 30 days and 90 days of their hospital stays. At the same time, they examined which patients were being discharged to high quality homes with available beds that were near the hospitals.The researchers determined that the probability of being readmitted to the hospital from a higher rated nursing home within 30 or 90 days decreased by 0.81 percentage points for patients with dementia. It decreased by only 0.34 percentage points if the patient did not have dementia.In addition, higher star ratings corresponded with reduced rates of patient deaths at both the 30 and 90 day marks, indicating that dementia patients are less likely to die or be readmitted to the hospital if they are discharged to a high quality nursing home.However, even if a greater number of beds were available at high quality nursing homes when patients were discharged from the hospital, the number of dementia patients accepted into those facilities did not change.This suggests that although dementia patients can benefit from higher quality nursing home care, they are less likely to receive that care, which has led Kosarโs team to conclude that there is a need for better efforts by hospital discharge staff to find high quality care for dementia patients.The researchers also concluded that additional incentives might be needed to encourage nursing homes to admit dementia patients. These could include different payment mechanisms or better risk adjustment methods.โIncentivizing nursing homes to treat patients with dementia is another potential avenue for reform. Historically, nursing homes have been reimbursed based on the level of skilled therapies provided with rudimentary case mix adjustment. It is likely that patients with dementia both generate low revenues and also have high ancillary costs associated with their care,โ Kosar said. โUnder a different payment mechanism and better risk adjustment, higher-quality nursing homes may find it more worthwhile to serve patients with dementia.โ Written by: Michael AdamsSenior Editor & JournalistMichael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers. Tags: Alzheimer's Disease, Dementia, Nursing Home, Nursing HomesMore Lawsuit Stories Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits August 21, 2026 Sexual Predator Groomed Teen Boy on Roblox Using Robux, Lawsuit Alleges August 21, 2026 AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter August 21, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 2 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026) Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 3 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026) FanDuel Addiction Lawsuit Alleges Targeted Advertising Caused Substantial Gambling Losses (Posted: 4 days ago)A FanDuel addiction lawsuit claims a Pennsylvania man wagered massive amounts of money after being subjected to a tailored promotional campaign designed to exploit his gambling habits.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Predictions Lawsuit Seeks Refunds for Illegal Sports Betting Losses (08/11/2026)Class Action Lawsuit Claims DraftKings Is Dodging State Gambling Laws (07/31/2026)Lawsuit Claims FanDuel, DraftKings Caused Compulsive Gambling, Addiction and Financial Losses (07/24/2026)
AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter August 21, 2026
Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 2 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026)
Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 3 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)
FanDuel Addiction Lawsuit Alleges Targeted Advertising Caused Substantial Gambling Losses (Posted: 4 days ago)A FanDuel addiction lawsuit claims a Pennsylvania man wagered massive amounts of money after being subjected to a tailored promotional campaign designed to exploit his gambling habits.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Predictions Lawsuit Seeks Refunds for Illegal Sports Betting Losses (08/11/2026)Class Action Lawsuit Claims DraftKings Is Dodging State Gambling Laws (07/31/2026)Lawsuit Claims FanDuel, DraftKings Caused Compulsive Gambling, Addiction and Financial Losses (07/24/2026)